Natalie began her career as a trade mark attorney at Zeneca Limited in 1996, and was responsible for a portfolio of marks in the specialties and agrochemical businesses as well as the pharmaceutical business.

Following the merger with Astra in 2000, she became a trade mark advisor at AstraZeneca with responsibility for the oncology and infection therapy area portfolios. During this time Natalie dealt with all aspects of domestic and international trade mark portfolio management, from creation, clearance and registration to enforcement, licensing and assignment, and post-patent expiry exploitation.

In 2001 she move into private practice, expanding her knowledge to many other product areas, including pharmaceutical and healthcare products, clothing, food and drink, household and building products. Natalie has been involved with several major divestment/acquisition projects for various clients. She also offers in-house consultancy services for clients with larger portfolios, or special projects.

Natalie joined Harrison IP in February 2007 and is based in Manchester. She is experienced in opposition and appeal procedures at the UK Trade Marks Registry and EUIPO and is an active member of the Chartered Institute of Trade Mark Attorneys (CITMA), Pharmaceutical Trade Marks Group (PTMG), and the International Trademarks Association (INTA).

Natalie is a director of Harrison IP.